Table 2B.

Antimicrobial susceptibility patterns of non-fermenter isolates

Antibiotic	Resistant isolates, n (%)
	A. baumannii	P. aeruginosa	S. maltophilia
	R	R	R
Ampicillin	12 (100)	6 (100)	2 (100)
Amoxicillin/clavulanic acid	10 (83.4)	6 (100)	2 (100)
Ampicillin/sulbactam	6 (50)	6 (100)	2 (100)
Piperacillin/tazobactam	9 (75)	2 (33)	0 (0)
Aztreonam	8 (66.6)	3 (50)	2 (100)
Meropenem	9 (75)	0 (0)	2 (100)
Imipenem	10 (83.4)	0 (0)	2 (100)
Cefoxitin	12 (100)	6 (100)	2 (100)
Cefepime	12 (100)	3 (50)	2 (100)
Ceftazidime	10 (83.4)	2 (33)	0 (0)
Cefotaxime	10 (83.4)	6 (100)	2 (100)
Ceftriaxone	8 (66.6)	4 (67)	2 (100)
Amikacin	9 (75)	0 (0)	0 (0)
Gentamicin	9 (75)	2 (33)	0 (0)
Tobramycin	4 (33.4)	0 (0)	0 (0)
Ciprofloxacin	10 (83.4)	0 (0)	0 (0)
Levofloxacin	5 (41.6)	2 (33)	0 (0)
Trimethoprim/sulfamethoxazole	9 (75)	4 (67)	0 (0)
Cefazolin	12 (100)	6 (100)	2 (100)
Ertapenem	10 (83.4)	4 (67)	2 (100)
Colistin	2 (16.6)	2 (33)	0 (0)
Total	12	6	2

Abbreviations: A. baumannii, Acinetobacter baumannii; P. aeruginosa, Pseudomonas aeruginosa; S. maltophilia, Stenotrophomonas maltophilia; R, resistant.